Laidlaw served as Co-Manager on the $15.4mm Soleno (SLNO) Follow-On Offering

Laidlaw Capital Markets is pleased to announce today’s pricing of Soleno Therapeutics (SLNO). Laidlaw served as Co-Manager for the $15,400,000 Follow-On Offering.

See full Press Release on SOLENO Website